The Venture Codex Logo

The Venture Codex

Alpaca VC

505 5th Ave, 22nd Floor, New York, NY, 10017, United States

Overview

Alpaca VC leads Seed rounds in founders that are reshaping the real world. We believe that layering technology over daily life transforms how the real world works, so we invest in the people, products, and processes that power commerce in the physical world. Led by a diverse team of company builders, operators, and analytical thinkers, Alpaca develops a repeatable playbook to help its entrepreneurs most efficiently progress from Seed to Series A.

Total investments
30
Lead investments
3
Investments · 12mo
4
Active investors
7

Sector focus

  • Finance
  • Financial Services
  • Venture Capital
Visit website

Investment portfolio

  • Applied Atomics

    Participated · Seed · Mar 2026

    Applied Atomics is building 100MW–1GW nuclear power plants co-located with large infrastructure campuses using established light-water reactor architecture and partnerships with industry players. The company emphasizes integrated plant design, supply chain control, and long-term operating capability. It plans to own and operate its plants and deliver electricity to customers under long-term power purchase agreements that provide predictable pricing and capacity assurance over multi-decade operating lives. Applied Atomics is led by CEO Benjamin Kellie and is based in Los Angeles, California. Following the recent financing, the company intends to expand its engineering, product, and deployment teams to scale internal execution capacity for designing, building, and operating its first plants.

  • Brilliant Harvest

    Participated · Seed · Feb 2026

    Brilliant Harvest is a Calgary-based technology company focused on the heavy equipment industry. Its core product is an AI customer experience platform that converts complex service and parts data into immediate guidance for dealership service, parts, and aftermarket teams, increasing wrench time and overall service efficiency. Deployed at dealership groups across North America, the platform aims to reduce downtime and streamline customer interactions. The solution leverages artificial intelligence to surface precise answers from technical documentation, manuals, and historical service records. Led by founder and CEO Remi Schmaltz, the company plans to use newly raised capital to expand operations and accelerate product development. While no specific revenue or user metrics were disclosed, the company’s growing customer base in North America signals early market traction.

  • Amplio

    Participated · Series A · Sep 2025

    Founded in 2021, Amplio develops AI agents that parse manufacturers’ massive surplus inventories, automatically flagging items that can be redeployed across facilities and valuing the rest for resale on the company’s curated private marketplace. The platform targets categories such as capital equipment, MRO parts, rolling stock, raw materials and finished goods, returning up to five times the industry-standard value to clients like Georgia-Pacific, NCR Voyix and Holland America. To date Amplio has diverted thousands of tons of equipment from landfills while returning millions of dollars in recovered value to customers. Headquartered in San Francisco and Atlanta, the company positions itself at the intersection of artificial intelligence, industrial resilience and the circular economy. With the new funding, Amplio plans to expand go-to-market operations and deepen its agentic system development, broadening coverage to additional surplus categories. The company believes intelligent, AI-native surplus management can unlock significant economic and environmental benefits across global manufacturing, a market it estimates generates $350 billion in U.S. waste annually and over $2 trillion worldwide.

  • Trially AI

    Participated · Seed · Sep 2025

    Trially AI has built a fully integrated, HIPAA-compliant platform that tackles the biggest bottleneck in clinical research—patient recruitment. Its core products include Trially Match, which analyzes unstructured EHR data to find eligible participants; Trially Connect, where the new agentic AI assistant “Margo” engages and pre-screens those candidates; and Trially Intelligence, a pipeline radar that flags suitable trials for a given patient population. The system can identify patients with roughly 95% screening accuracy, enroll 2–6× more patients per month in complex trials, reduce screen failures by 73%, and cut manual chart-review time by 91%. One research site network reported a $4 million revenue increase within three months of deployment, and users see as much as a 10× jump in identified trial candidates. The company positions itself for physicians, research sites, CROs, and pharmaceutical sponsors needing faster, more diverse enrollment. With fresh seed funding, management plans to accelerate platform adoption across research sites, sponsors, CROs, and physician networks. Financially, Trially AI has secured $4.7 million in seed capital to fuel this next phase of growth.

  • Foyer

    Led · Seed · Jan 2025

    Foyer offers a dedicated savings platform for prospective homebuyers that lets users create target savings goals, access personalized guidance on saving and mortgage information, and earn rewards usable toward a home purchase. The company operates a subscription model for members seeking additional support and can connect users with real estate professionals. Founder Landy Liu, who launched Foyer after pausing his own home purchase, is both CEO and an early user of the product. Foyer launched last year in Michigan and has since expanded nationwide, claiming more than 10,000 users. The product positions itself as a “401k for homeownership,” combining high-yield savings, education, and strategic partnerships. The company says the new capital will be used to expand and enhance product features.

Team